GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Athersys Inc (FRA:4LSA) » Definitions » Ending Cash Position

Athersys (FRA:4LSA) Ending Cash Position : €0.96 Mil (As of Sep. 2023)


View and export this data going back to 2008. Start your Free Trial

What is Athersys Ending Cash Position?

Athersys's Ending Cash Position for the quarter that ended in Sep. 2023 was €0.96 Mil.

Athersys's quarterly Ending Cash Position declined from Mar. 2023 (€2.92 Mil) to Jun. 2023 (€1.66 Mil) and declined from Jun. 2023 (€1.66 Mil) to Sep. 2023 (€0.96 Mil).

Athersys's annual Ending Cash Position declined from Dec. 2020 (€42.37 Mil) to Dec. 2021 (€33.11 Mil) and declined from Dec. 2021 (€33.11 Mil) to Dec. 2022 (€8.53 Mil).


Athersys Ending Cash Position Historical Data

The historical data trend for Athersys's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Athersys Ending Cash Position Chart

Athersys Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 44.88 31.54 42.37 33.11 8.53

Athersys Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.92 8.53 2.92 1.66 0.96

Athersys Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Athersys's Ending Cash Position for the fiscal year that ended in Dec. 2022 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=35.312+-26.78
=8.53

Athersys's Ending Cash Position for the quarter that ended in Sep. 2023 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=1.69+-0.734
=0.96


Athersys Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Athersys's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.


Athersys (FRA:4LSA) Business Description

Traded in Other Exchanges
Address
3201 Carnegie Avenue, Cleveland, OH, USA, 44115-2634
Athersys Inc is a biotechnology company engaged in the field of regenerative medicine. It consists of research, clinical development, manufacturing, and manufacturing process development activities. The firm's main product is Multistem cell therapy. Its clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and certain pulmonary conditions. Its revenue has been derived from corporate collaborations, license agreements, and government grants.

Athersys (FRA:4LSA) Headlines

No Headlines